ANI PHARMACEUTICALS, INC Adjustments to Additional Paid in Capital, Warrant Issued
ANI PHARMACEUTICALS, INC (ANIP) reported Adjustments to Additional Paid in Capital, Warrant Issued of $204.98 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2013-02-28.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2013-02-28
- ANI PHARMACEUTICALS, INC adjustments to additional paid in capital, warrant issued for fiscal 2011 was $204.98K, a 212.81% increase from fiscal 2010.
- ANI PHARMACEUTICALS, INC adjustments to additional paid in capital, warrant issued for fiscal 2010 was $65.53K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|
| 2011-12-31 | $204.98K 10-K · filed 2013-02-28 |
| 2010-12-31 | $65.53K 10-K · filed 2013-02-28 |
| 2009-12-31 | $64.10K 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |